Top 10 Pharmaceuticals markets in SingaporeThe fastest-growing and largest of the 20 sized Pharmaceuticals markets in Singapore, 2023 to 2033, with active clinical trials.
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Biosimilars | $44 Mn | $429 Mn | 25.5% | 5 |
| 2 | Cell Based Immunotherapy | $20 Mn | $166 Mn | 23.6% | 222 |
| 3 | Cannabidiol (CBD) | $27 Mn | $132 Mn | 17.4% | 1 |
| 4 | Cannabis | $41 Mn | $152 Mn | 14.1% | 0 |
| 5 | Atopic Dermatitis Drugs | $14 Mn | $45 Mn | 12.8% | 5 |
| 6 | Oncology/Cancer Drugs | $212 Mn | $503 Mn | 9% | 318 |
| 7 | Anti-Aging | $106 Mn | $244 Mn | 8.7% | 43 |
| 8 | Diabetes Management | $94 Mn | $197 Mn | 7.7% | 34 |
| 9 | Alzheimer Drugs | $6 Mn | $12 Mn | 7.4% | 10 |
| 10 | Contraceptives Drugs | $30 Mn | $62 Mn | 7.4% | 0 |
| # | Market | 2023 | 2033 (projected) | CAGR | Active trials |
|---|---|---|---|---|---|
| 1 | Oncology/Cancer Drugs | $212 Mn | $503 Mn | 9% | 318 |
| 2 | Anti-Aging | $106 Mn | $244 Mn | 8.7% | 43 |
| 3 | Diabetes Management | $94 Mn | $197 Mn | 7.7% | 34 |
| 4 | Gastrointestinal Drugs | $65 Mn | $108 Mn | 5.2% | 96 |
| 5 | Asthma & COPD Drugs | $59 Mn | $93 Mn | 4.6% | 6 |
| 6 | Biosimilars | $44 Mn | $429 Mn | 25.5% | 5 |
| 7 | Cannabis | $41 Mn | $152 Mn | 14.1% | 0 |
| 8 | HIV Drugs | $36 Mn | $67 Mn | 6.4% | 1 |
| 9 | Contraceptives Drugs | $30 Mn | $62 Mn | 7.4% | 0 |
| 10 | Cancer Supportive Care Drugs | $30 Mn | $50 Mn | 5.3% | 44 |
2033 values are projected from the 2023 size and the CAGR. Each market name opens its report. Active trials: recruiting, about to start or running.
Biosimilars grows fastest, at 25.5% a year from 2023 to 2033, ahead of Cell Based Immunotherapy (23.6%).
Oncology/Cancer Drugs is the largest, worth about $212 Mn in 2023 and $503 Mn by 2033 (projected).
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide.
China
India
Japan
Australia
Hong Kong
Philippines
Thailand
Malaysia